Need to file an Actos lawsuit? Contact Williams Kherkher today at 800-641-9810.

Actos replacement denied by FDA

Posted on May 1st, 2012 No Comments

While Actos is being plagued by its link to numerous life-threatening ailments, its heir may be facing guilt by association.

Takeda Pharmaceutical’s patent on pioglitazone (the active ingredient in Actos) is due to run out this August. The company will soon be facing competition from generic pioglitazone manufacturers. Because of this, the company is hoping to acquire FDA approval for its next generation of diabetes drug as soon as possible.

The drug has been rejected twice. It was first denied in 2009 because the FDA wanted more information on its heart risks. The reasons behind last week’s rejection are still unclear, but it may have something to do with the FDA lacking faith in alogliptin, the new drug’s active ingredient.

Actos has been linked to several life-threatening conditions. If you have taken Actos and been diagnosed with bladder cancer, contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810.

Tagged , , | Leave a comment

Contact Williams Kherkher




By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

home  |  about us  |  attorneys  |  actos  |  bladder cancer  |  faqs  |  articles  |  law resources  |  press release  |  contact us  |  blog  |  Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +